Abstract
In the present study, the concentrations of estrone (E 1), estradiol (E 2) and their sulfates (E 1S and E 2S), as well as the sulfatase and aromatase activities, were evaluated in post-menopausal patients with breast cancer. Comparative studies of the evaluation of these parameters were carried out in (a) tumor tissue, (b) areas surrounding the tumor, and (c) areas distant from the tumor (glandular tissue) which were considered as normal tissue. The levels (in pm/g; mean ± SEM) were: for E 1 in the (a) area: 320±95; in (b): 232±86; and in (c): 203±71; for E 2 in the (a) area: 388±106; in (b): 224±48; and in (c): 172±80; for E 1S in the (a) area: 454±110; in (b): 259±90; and in (c): 237±65; for E 2S in the (a) area:318±67; in (b): 261±72; and in (c): 232±75, respectively. The values of E 1S and E 2 were significantly higher in the tumor tissue than in the area considered as normal. In all the tissues studied, the sulfatase activity was much higher than aromatase (130–200). In addition, the sulfatase levels were significantly higher in the peripheral and in the tumor tissue than in the area considered as normal. The levels of aromatase were significantly higher in tumoral than in normal tissue. The present data extend the “intracrine concept” for breast cancer tumors. The physiopathology and clinical significance as promoter parameters in breast cancer is to be explored.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: The Journal of Steroid Biochemistry and Molecular Biology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.